Chain of Custody and Sample Traceability
Chain of custody records how a sample moves from its source through handling, transfer and laboratory receipt. Sample traceability connects that history to the material and report identifiers. A genuine laboratory report can still leave an unanswered question about which lot was sampled or what happened before the laboratory received it.
Establish the sample's starting point
Begin with the source material, the sample identifier and the collection event. An identifier written on a submission form becomes useful when a record connects it to the material from which the sample was taken. Lot numbers and traceability explains the separate role of the container's lot reference.
As a documentation example, FDA's ICH Q7 guidance connects laboratory samples with material or source, batch or other code, sampling date and relevant receipt details. [A6] Q7 concerns pharmaceutical ingredients; its record structure is not evidence of Knockout Labs compliance or proof that these records have been supplied.
For a lot review, distinguish “sample submitted as lot DEMO-L1” from “sampling record connects this sample to lot DEMO-L1”. The first reports a label or declaration. The second requires a supporting record. Neither phrase, by itself, establishes that the sample represents every container in the lot.
Follow transfers and changes of identifier
EPA's sample-management procedure treats custody as both control of the sample and a documented history of possession. It records collection information and transfers through to laboratory receipt. [A5] This is an environmental field procedure, used here as a documentation example rather than a rule for research-peptide suppliers.
The following is a suggested reading checklist. It is not a validated sampling or transport procedure.
| Stage to check | Connection to look for | Gap to describe accurately |
|---|---|---|
| Collection | Source lot or container connected to the new sample ID | Source recorded, but the sampling event is not supplied |
| Dispatch and transfer | Identified sample, handover record and shipment reference | Dispatch is documented, but the next custody event is missing |
| Laboratory receipt | Submitted ID linked to the laboratory's accession ID and receipt record | Report has a laboratory ID with no supplied link to the submitted sample |
| Preparation or division | Any aliquot or preparation ID connected to its parent sample | Analysis refers to a new ID whose parent is unclear |
| Report or retained portion | Tested or retained material connected to the relevant sample record | A report or stored portion is named without a demonstrated link |
An accession number is the laboratory's reference for a received sample. It need not be identical to the supplier's lot number. Different identifiers can be legitimate when their relationship is documented; copying one number into every field would not improve the evidence.
Work through a fictional missing handover
All identifiers, times and events in this example are invented. The times share one stated time zone, UTC.
| Recorded event | Fictional entry | Interpretation |
|---|---|---|
| 10 October 2026, 09:10 | Sampling sheet connects lot DEMO-L1 to sample DEMO-S7 | The source-to-sample link is documented in this example |
| 10 October 2026, 11:00 | Dispatch log records DEMO-S7; carrier receipt is absent | A transfer question remains |
| 11 October 2026, 08:40 | Laboratory receipt connects DEMO-S7 to accession DEMO-204 | The laboratory link exists, but does not fill the earlier gap |
| 12 October 2026 | Report DEMO-R9 cites accession DEMO-204 | The report can be traced to laboratory receipt |
A precise review note would say: “The supplied records connect DEMO-R9 to DEMO-S7 and lot DEMO-L1, but custody between dispatch and laboratory receipt is not fully documented.” It would not say that substitution occurred. Missing documentation and evidence of substitution are different findings.
Ask whether an existing carrier, transfer or receipt record resolves the interval. Do not invent a handover signature, rewrite the original entry or assume that a later report authenticates every earlier event. Matching a certificate to a batch and container covers the separate document-matching exercise.
Custody does not establish representativeness
A complete history for one sample shows what happened to that sample. It does not explain whether the collection plan adequately represented a bulk lot, several containers or a changing material. That requires the sampling rationale and relevant procedure.
Similarly, a recorded storage interval is not proof that the material stayed within appropriate conditions. Where conditions matter, request the applicable instruction and available condition or deviation record. Do not infer a universal temperature, transport duration or retention period from this guide.
A retained sample is material kept for possible later examination. Ask which sample or lot it came from, how it is identified and what handling history is recorded. Retention does not automatically make an old sample equivalent to the material originally tested, and this page does not confirm a Knockout Labs retention arrangement.
Ask for the missing connection
A focused request names the two records you cannot connect: “Please clarify how laboratory sample DEMO-204 relates to the submitted sample and source lot, and whether any receipt exception was recorded.” Replace the fictional references with the exact identifiers in your own documents.
The sourcing and release overview provides context for supplier documentation. Batch release, quarantine and rejection covers the material's decision status, which a custody record alone cannot establish. Return to the quality-documentation hub for the broader evidence routes.
References
These sources support the stated analytical and documentation principles. Pharmaceutical guidance and environmental procedures have their own scope; their citation does not establish supplier compliance, actual testing or a lot result. Manufacturer documentation does not identify a Knockout Labs supplier.
- [A5] Sample and Evidence Management, FSBPROC-005-R6. US EPA Region 4. Revision 6; cover effective date 8 November 2024. Sections 2.2.1 and 2.3–2.5.
- [A6] Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. FDA / ICH. September 2016, revision 1. Section 6.6, laboratory control records; glossary, batch number.
Sources accessed 23 October 2026. Examples, calculations and record ledgers are original educational illustrations with invented inputs.